GDC-0810

Generic Name
GDC-0810
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C26H20ClFN2O2
CAS Number
1365888-06-7
Unique Ingredient Identifier
9MM2R1A06R
Background

ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.

Associated Conditions
-
Associated Therapies
-

Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-12-04
Last Posted Date
2016-11-02
Lead Sponsor
Genentech, Inc.
Target Recruit Count
15
Registration Number
NCT02621957

A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2015-10-07
Last Posted Date
2021-04-23
Lead Sponsor
Genentech, Inc.
Target Recruit Count
71
Registration Number
NCT02569801
Locations
🇺🇸

Florida Cancer Specialists-Broadway, Fort Myers, Fort Myers, Florida, United States

🇺🇸

Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building), Saint Petersburg, Florida, United States

🇺🇸

The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth, Texas, United States

and more 41 locations

A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

First Posted Date
2013-04-04
Last Posted Date
2021-06-18
Lead Sponsor
Genentech, Inc.
Target Recruit Count
152
Registration Number
NCT01823835
Locations
🇳🇱

VU MEDISCH CENTRUM; Dept. of Medical Oncology, Amsterdam, Netherlands

🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

and more 11 locations
© Copyright 2024. All Rights Reserved by MedPath